AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Ranitidine Hydrochloride in South Africa
9 products registered with SAHPRA — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ZANTAC-RANITIDINE 300 | 28/11.4.3/0438 | Pharmacare Limited û Woodmead | suspended | 16 Sept 2025 |
| RANTEEN 300 mg | 30/11.4.3/0037 | Pharmacare Limited û Woodmead | suspended | 29 Jul 2024 |
| RANTAC 150 | 28/11.4.3/0025 | Pharmacare Limited û Woodmead | suspended | 29 Jul 2024 |
| RANTAC INJECTION | 28/11.4.3/0096 | Pharmacare Limited û Woodmead | suspended | 29 Jul 2024 |
| RANTEEN 150 mg | 30/11.4.3/0036 | Pharmacare Limited û Woodmead | suspended | 29 Jul 2024 |
| GLAX0-RANITIDINE 150 | 28/11.4.3/0255 | Pharmacare Limited û Woodmead | suspended | 29 Jul 2024 |
| GLAX0-RANITIDINE 300 | 28/11.4.3/0256 | Pharmacare Limited û Woodmead | suspended | 29 Jul 2024 |
| EBUNAZIINJECTION | 28/11.4.3/0095 | Bliss Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
| EBUNAZI 300 TABLETS | 28/11.4.3/0024 | Bliss Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
Ranitidine Hydrochloride — SAHPRA Registration Details
SAHPRA (South Africa) has 9 registered products containing Ranitidine Hydrochloride, of which 2 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Ranitidine Hydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.